Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Proto Script Pharmaceutical Corp.

Market Cap 1.97M 1.69M 1.56M 1.46M 2.75M 186M 2.78M 18.43M 7.18M 91.01M 7.38M 7.22M 315M P/E Ratio 2015 *
-
P/E Ratio 2016 -41.4x
Enterprise Value 2.01M 1.74M 1.6M 1.5M 2.82M 190M 2.85M 18.88M 7.36M 93.22M 7.56M 7.4M 323M EV / Sales 2015 *
-
EV / Sales 2016 394x
Free-Float
89.82%
Yield 2015 *
-
Yield 2016 -
1 month+100.00%
3 months+100.00%
6 months+100.00%
Current year+100.00%
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0.02
10 years 0
Extreme 0
2.2
Manager TitleAgeSince
Chief Executive Officer 58 29/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-33.33%0.00% 11.38K
+0.08%-2.74%-21.36%+42.42% 69.91B
+0.17%+4.02%+3.50%+93.48% 20.57B
+0.18%-0.49%-3.77%+7.09% 14.71B
+0.19%+3.56%-10.68%+3.32% 13.46B
+0.26%+2.81%+18.88%+29.15% 11.69B
-1.36%-2.15%+37.49%+99.83% 8.45B
-0.83%+3.39%+48.53%+90.98% 6.46B
+0.40%-4.72%-29.41%-20.51% 5.25B
-1.11%+0.16%-2.04%-9.22% 5.18B
Average -0.14%+1.52%+0.78%+33.65% 15.57B
Weighted average by Cap. -0.00%+0.72%-6.01%+42.74%

Financials

2015 2016
Net sales 881K 760K 699K 657K 1.23M 83.34M 1.25M 8.27M 3.22M 40.81M 3.31M 3.24M 141M 789K 680K 626K 588K 1.1M 74.59M 1.12M 7.4M 2.88M 36.53M 2.96M 2.9M 127M
Net income -145K -125K -115K -108K -203K -13.73M -205K -1.36M -531K -6.72M -545K -534K -23.31M -7.18M -6.19M -5.7M -5.35M -10.05M -679M -10.15M -67.36M -26.24M -333M -26.96M -26.38M -1.15B
Net Debt 27.07K 23.33K 21.48K 20.17K 37.87K 2.56M 38.27K 254K 98.89K 1.25M 102K 99.43K 4.34M 47.78K 41.18K 37.92K 35.6K 66.85K 4.52M 67.55K 448K 175K 2.21M 179K 176K 7.67M
Logo Proto Script Pharmaceutical Corp.
Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.
Employees
13
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. PSCR Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!